FINDING NOVEL REAGENTS BY BIOINFORMATICS AND BIOCHEMISTRY
Award amount
$218,685Program and phase
SBIR · Phase IAward year
2012Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- NEW ENGLAND BIOLABS, INC.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- EDKJNT8DADG8
- Solicitation number
- PA11-096
- Topic code
- NIGMS
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Novel 5-methylcytosine Oxidases
- Studies of DNA Methyltransferases
- Structure guided rational engineering of novel DNA reagents.
- Structure guided rational engineering of novel DNA reagents.
- NOVEL 5-HYDROXYMETHYLCYTOSINE SPECIFIC ENZYMES FOR EPIGENETIC STUDIES.
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Three-Dimensional Spatio-Temporal Control of Lipid Nanoparticle Manufacturing for Improved Nucleic Acid Delivery
- Paradigm-changing, versatile, scalable and cost-effective technology for monthly injections of peptide drugs
- Project MATCH: Multi-spectral AI/ML powered Burn and Wound Evaluation Technology using a Cost-Effective Handheld Device.
- A versatile platform to isolate cells from three-dimensional samples after spatial and temporal profiling
- Development of an Educational Product for Accelerating Solutions for Commercialization and Entrepreneurial Development (ASCEND) in Western IDeA States
Research funding history
40 SBIR/STTR records share this UEI (1994–2013). Reported award amounts total $12,787,343. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, National Science Foundation